These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16050427)

  • 21. Impact of estrogen therapy on Alzheimer's disease: a fork in the road?
    Brinton RD
    CNS Drugs; 2004; 18(7):405-22. PubMed ID: 15139797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease?
    Mills ZB; Faull RLM; Kwakowsky A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics.
    Sano M; Jacobs D; Andrews H; Bell K; Graff-Radford N; Lucas J; Rabins P; Bolla K; Tsai WY; Cross P; Andrews K; Costa R; Xiaodong Luo
    Clin Trials; 2008; 5(5):523-33. PubMed ID: 18827045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.
    Zandi PP; Carlson MC; Plassman BL; Welsh-Bohmer KA; Mayer LS; Steffens DC; Breitner JC;
    JAMA; 2002 Nov; 288(17):2123-9. PubMed ID: 12413371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The menopause and HRT. HRT and cognitive decline.
    Maki P; Hogervorst E
    Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):105-22. PubMed ID: 12763515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy--is there a place for its use in neurology?
    Vuković V; Lovrencić-Huzjan A; Solter VV; Dordević V; Demarin V
    Coll Antropol; 2003 Jun; 27(1):413-24. PubMed ID: 12974172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease and other neurological disorders.
    Henderson VW
    Climacteric; 2007 Oct; 10 Suppl 2():92-6. PubMed ID: 17882682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone replacement therapy and risk of acute myocardial infarction : a review of the literature.
    Bromley SE; de Vries CS; Thomas D; Farmer RD
    Drug Saf; 2005; 28(6):473-93. PubMed ID: 15924502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life.
    Almeida OP; Lautenschlager NT; Vasikaran S; Leedman P; Gelavis A; Flicker L
    Neurobiol Aging; 2006 Jan; 27(1):141-9. PubMed ID: 16298249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Action of estrogens in the aging brain: dementia and cognitive aging.
    Henderson VW
    Biochim Biophys Acta; 2010 Oct; 1800(10):1077-83. PubMed ID: 19913598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models.
    Sohrabji F
    Ann N Y Acad Sci; 2005 Jun; 1052():75-90. PubMed ID: 16024752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline.
    Resnick SM; Coker LH; Maki PM; Rapp SR; Espeland MA; Shumaker SA
    Clin Trials; 2004; 1(5):440-50. PubMed ID: 16279282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What we know about estrogen's effect on the brain.
    Mitchell JL
    Curr Womens Health Rep; 2002 Oct; 2(5):382-9. PubMed ID: 12215311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease, menopause and the impact of the estrogenic environment.
    Pines A
    Climacteric; 2016 Oct; 19(5):430-2. PubMed ID: 27327261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause.
    Lobo RA; Pickar JH; Stevenson JC; Mack WJ; Hodis HN
    Atherosclerosis; 2016 Nov; 254():282-290. PubMed ID: 27745704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone Replacement Therapy and Alzheimer's Disease: Current State of Knowledge and Implications for Clinical Use.
    Sayfullaeva J; McLoughlin J; Kwakowsky A
    J Alzheimers Dis; 2024; 101(s1):S235-S261. PubMed ID: 39422965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lifelong endocrine fluctuations and related cognitive disorders.
    Ancelin ML; Ritchie K
    Curr Pharm Des; 2005; 11(32):4229-52. PubMed ID: 16375742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case-control study of increased mammographic breast density response to hormone replacement therapy.
    Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should progestins be blamed for the failure of hormone replacement therapy to reduce cardiovascular events in randomized controlled trials?
    Koh KK; Sakuma I
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1171-9. PubMed ID: 15130916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.